MRSN·59045L106·UQ·equity·Healthcare - Biotechnology-Activist
MRSN (MERSANA THERAPEUTICS INC) is held by 27 institutional investors as of Q4 2025. Largest holders: VANGUARD GROUP INC ($6.1M), BlackRock, Inc. ($2M), BANK OF AMERICA CORP /DE/ ($1.9M). Net institutional sentiment: Bearish.
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer